Tyrosinemia: Difference between revisions

Revision as of 23:49, 9 February 2025

A genetic disorder affecting tyrosine metabolism

Chemical structure of L-tyrosine

Tyrosinemia is a genetic disorder characterized by elevated levels of the amino acid tyrosine in the blood. This condition is caused by a deficiency in one of the enzymes responsible for the breakdown of tyrosine, leading to its accumulation and associated health problems.

Types

There are three main types of tyrosinemia, each caused by a deficiency in a different enzyme involved in tyrosine metabolism:

Tyrosinemia type I (hepatorenal tyrosinemia) is the most severe form and is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH). This type can lead to liver and kidney failure, as well as neurological problems.

Tyrosinemia type II (oculocutaneous tyrosinemia) is caused by a deficiency of the enzyme tyrosine aminotransferase (TAT). It primarily affects the eyes, skin, and mental development.

Tyrosinemia type III is the rarest form and is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPD). It can lead to neurological problems.

Genetics

File:Autorecessive.svg

Tyrosinemia is inherited in an autosomal recessive pattern.

Tyrosinemia is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. Carriers, who have only one copy of the mutated gene, typically do not show symptoms.

Pathophysiology

File:Inborn errors of metabolism of phenylalanine and tyrosine.svg

Inborn errors of metabolism of phenylalanine and tyrosine

The accumulation of tyrosine and its metabolites in the body can lead to a variety of symptoms and complications, depending on the type of tyrosinemia. In type I, the accumulation of toxic metabolites can cause severe liver and kidney damage. In type II, the buildup of tyrosine affects the eyes and skin, while in type III, neurological issues are more prominent.

Diagnosis

Diagnosis of tyrosinemia is typically made through blood and urine tests that measure the levels of tyrosine and its metabolites. Genetic testing can confirm the specific enzyme deficiency and type of tyrosinemia.

Treatment

Treatment for tyrosinemia varies depending on the type but often includes dietary restrictions to limit tyrosine intake. For type I, the drug nitisinone (NTBC) is used to block the formation of toxic metabolites. Liver transplantation may be necessary in severe cases.

Prognosis

With early diagnosis and appropriate treatment, individuals with tyrosinemia can lead relatively normal lives. However, untreated tyrosinemia, especially type I, can lead to severe complications and reduced life expectancy.

Related pages

References

@@ Line 1: / Line 1: @@
-'''Tyrosinemia''' is a group of rare genetic disorders characterized by disruptions in the metabolic pathway of the amino acid tyrosine. This results in an accumulation of tyrosine and its by-products in the body, leading to a variety of health problems. There are three types of tyrosinemia, each with distinct symptoms and treatment options.
+{{Short description|A genetic disorder affecting tyrosine metabolism}}
+{{Use dmy dates|date=October 2023}}
-==Types of Tyrosinemia==
+[[File:L-tyrosine-skeletal.png|thumb|right|Chemical structure of L-tyrosine]]
-There are three types of tyrosinemia, each caused by the deficiency of a different enzyme involved in the metabolic pathway of tyrosine.
-===Tyrosinemia Type I===
+'''Tyrosinemia''' is a genetic disorder characterized by elevated levels of the amino acid [[tyrosine]] in the blood. This condition is caused by a deficiency in one of the enzymes responsible for the breakdown of tyrosine, leading to its accumulation and associated health problems.
-[[Tyrosinemia Type I]] is the most severe form of the disorder. It is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH). Symptoms usually appear in the first few months of life and include failure to gain weight and grow at the expected rate (failure to thrive), diarrhea, vomiting, yellowing of the skin and whites of the eyes (jaundice), and a cabbage-like odor.
-===Tyrosinemia Type II===
+==Types==
-[[Tyrosinemia Type II]], also known as Richner-Hanhart syndrome, is caused by a deficiency of the enzyme tyrosine aminotransferase (TAT). Symptoms can include painful skin lesions on the palms and soles, eye abnormalities, and intellectual disability.
+There are three main types of tyrosinemia, each caused by a deficiency in a different enzyme involved in tyrosine metabolism:
-===Tyrosinemia Type III===
+* '''Tyrosinemia type I''' (hepatorenal tyrosinemia) is the most severe form and is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH). This type can lead to liver and kidney failure, as well as neurological problems.
-[[Tyrosinemia Type III]] is the rarest form of the disorder and is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPD). Symptoms can include intellectual disability, seizures, and periodic loss of balance and coordination (ataxia).
+* '''Tyrosinemia type II''' (oculocutaneous tyrosinemia) is caused by a deficiency of the enzyme tyrosine aminotransferase (TAT). It primarily affects the eyes, skin, and mental development.
+* '''Tyrosinemia type III''' is the rarest form and is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPD). It can lead to neurological problems.
+==Genetics==
+[[File:Autorecessive.svg|thumb|right|Tyrosinemia is inherited in an autosomal recessive pattern.]]
+Tyrosinemia is inherited in an [[autosomal recessive]] pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected by the disorder. Carriers, who have only one copy of the mutated gene, typically do not show symptoms.
+==Pathophysiology==
+[[File:Inborn_errors_of_metabolism_of_phenylalanine_and_tyrosine.svg|thumb|right|Inborn errors of metabolism of phenylalanine and tyrosine]]
+The accumulation of tyrosine and its metabolites in the body can lead to a variety of symptoms and complications, depending on the type of tyrosinemia. In type I, the accumulation of toxic metabolites can cause severe liver and kidney damage. In type II, the buildup of tyrosine affects the eyes and skin, while in type III, neurological issues are more prominent.
 ==Diagnosis==
-Diagnosis of tyrosinemia is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests can include blood and urine tests, genetic testing, and liver biopsy.
+Diagnosis of tyrosinemia is typically made through blood and urine tests that measure the levels of tyrosine and its metabolites. Genetic testing can confirm the specific enzyme deficiency and type of tyrosinemia.
 ==Treatment==
-Treatment of tyrosinemia is aimed at managing the symptoms and preventing complications. This can include a low-protein diet, medications, and in some cases, liver transplantation.
+Treatment for tyrosinemia varies depending on the type but often includes dietary restrictions to limit tyrosine intake. For type I, the drug nitisinone (NTBC) is used to block the formation of toxic metabolites. Liver transplantation may be necessary in severe cases.
+==Prognosis==
+With early diagnosis and appropriate treatment, individuals with tyrosinemia can lead relatively normal lives. However, untreated tyrosinemia, especially type I, can lead to severe complications and reduced life expectancy.
-==See Also==
+==Related pages==
-* [[Amino acid metabolism disorder]]
+* [[Phenylketonuria]]
-* [[Genetic disorder]]
+* [[Alkaptonuria]]
-* [[Metabolic disorder]]
+* [[Maple syrup urine disease]]
-[[Category:Genetic disorders]]
+==References==
-[[Category:Metabolic disorders]]
+{{Reflist}}
-[[Category:Rare diseases]]
-{{stub}}
+[[Category:Inborn errors of metabolism]]
+[[Category:Autosomal recessive disorders]]